Homo sapiens Protein: GABRG2 | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||
InnateDB Protein | IDBP-56455.5 | ||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||
Gene Symbol | GABRG2 | ||||||||||||||||||||||
Protein Name | gamma-aminobutyric acid (GABA) A receptor, gamma 2 | ||||||||||||||||||||||
Synonyms | CAE2; ECA2; GEFSP3; | ||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||
Ensembl Protein | ENSP00000354651 | ||||||||||||||||||||||
InnateDB Gene | IDBG-56451 (GABRG2) | ||||||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||
Function | Component of the heteropentameric receptor for GABA, the major inhibitory neurotransmitter in the vertebrate brain. Functions also as histamine receptor and mediates cellular responses to histamine. Functions as receptor for diazepines and various anesthetics, such as pentobarbital; these are bound at a separate allosteric effector binding site. Functions as ligand- gated chloride channel. {ECO:0000269PubMed:2538761}. | ||||||||||||||||||||||
Subcellular Localization | Cell junction, synapse, postsynaptic cell membrane {ECO:0000269PubMed:2538761}; Multi-pass membrane protein {ECO:0000269PubMed:2538761}. Cell membrane {ECO:0000269PubMed:2538761}; Multi-pass membrane protein {ECO:0000269PubMed:2538761}. | ||||||||||||||||||||||
Disease Associations | Epilepsy, childhood absence 2 (ECA2) [MIM:607681]: A subtype of idiopathic generalized epilepsy characterized by an onset at age 6-7 years, frequent absence seizures (several per day) and bilateral, synchronous, symmetric 3-Hz spike waves on EEG. Tonic-clonic seizures often develop in adolescence. Some individuals manifest febrile seizures. Absence seizures may either remit or persist into adulthood. {ECO:0000269PubMed:11326275}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.Febrile seizures, familial, 8 (FEB8) [MIM:611277]: Seizures associated with febrile episodes in childhood without any evidence of intracranial infection or defined pathologic or traumatic cause. It is a common condition, affecting 2-5% of children aged 3 months to 5 years. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy. {ECO:0000269PubMed:16924025}. Note=The disease is caused by mutations affecting the gene represented in this entry.Generalized epilepsy with febrile seizures plus 3 (GEFS+3) [MIM:611277]: A rare autosomal dominant, familial condition with incomplete penetrance and large intrafamilial variability. Patients display febrile seizures persisting sometimes beyond the age of 6 years and/or a variety of afebrile seizure types. This disease combines febrile seizures, generalized seizures often precipitated by fever at age 6 years or more, and partial seizures, with a variable degree of severity. {ECO:0000269PubMed:11326274}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||||||
Tissue Specificity | |||||||||||||||||||||||
Comments | |||||||||||||||||||||||
Interactions | |||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 4 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
|
||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||
InterPro |
IPR001390
Gamma-aminobutyric-acid A receptor, alpha subunit IPR005437 Gamma-aminobutyric-acid A receptor, gamma subunit IPR005439 Gamma-aminobutyric-acid A receptor, gamma 2 subunit IPR006028 Gamma-aminobutyric acid A receptor/Glycine receptor alpha IPR006029 Neurotransmitter-gated ion-channel transmembrane domain IPR006201 Neurotransmitter-gated ion-channel IPR006202 Neurotransmitter-gated ion-channel ligand-binding |
||||||||||||||||||||||
PFAM |
PF02932
PF02931 |
||||||||||||||||||||||
PRINTS |
PR01079
PR01620 PR01622 PR00253 PR00252 |
||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||
SMART | |||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||
Modification | |||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||
SwissProt | P18507 | ||||||||||||||||||||||
PhosphoSite | PhosphoSite-P18507 | ||||||||||||||||||||||
TrEMBL | E5RGG2 | ||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||
Entrez Gene | 2566 | ||||||||||||||||||||||
UniGene | Hs.7195 | ||||||||||||||||||||||
RefSeq | NP_000807 | ||||||||||||||||||||||
HUGO | HGNC:4087 | ||||||||||||||||||||||
OMIM | 137164 | ||||||||||||||||||||||
CCDS | CCDS4358 | ||||||||||||||||||||||
HPRD | 00663 | ||||||||||||||||||||||
IMGT | |||||||||||||||||||||||
EMBL | AC008611 AC091926 AC091984 AF165124 AK299640 BC059389 BC069348 BC074795 X15376 | ||||||||||||||||||||||
GenPept | AAD50273 AAH59389 AAH69348 AAH74795 BAG61563 CAA33437 | ||||||||||||||||||||||